[go: up one dir, main page]

MA23953A1 - Procede nouveau pour formuler des formes posologiques solides, et formes posologiques ainsi produites - Google Patents

Procede nouveau pour formuler des formes posologiques solides, et formes posologiques ainsi produites

Info

Publication number
MA23953A1
MA23953A1 MA24329A MA24329A MA23953A1 MA 23953 A1 MA23953 A1 MA 23953A1 MA 24329 A MA24329 A MA 24329A MA 24329 A MA24329 A MA 24329A MA 23953 A1 MA23953 A1 MA 23953A1
Authority
MA
Morocco
Prior art keywords
dosage forms
produced
new process
formulating solid
solid dosage
Prior art date
Application number
MA24329A
Other languages
English (en)
French (fr)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA23953A1 publication Critical patent/MA23953A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA24329A 1995-07-29 1996-07-26 Procede nouveau pour formuler des formes posologiques solides, et formes posologiques ainsi produites MA23953A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process

Publications (1)

Publication Number Publication Date
MA23953A1 true MA23953A1 (fr) 1997-04-01

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24329A MA23953A1 (fr) 1995-07-29 1996-07-26 Procede nouveau pour formuler des formes posologiques solides, et formes posologiques ainsi produites

Country Status (25)

Country Link
EP (1) EP0841902A2 (es)
JP (1) JPH11510493A (es)
KR (1) KR19990035972A (es)
CN (1) CN1196677A (es)
AP (1) AP858A (es)
AR (1) AR004178A1 (es)
AU (1) AU716961B2 (es)
BG (1) BG102266A (es)
BR (1) BR9609804A (es)
CA (1) CA2228048A1 (es)
CZ (1) CZ24798A3 (es)
DZ (1) DZ2077A1 (es)
EA (2) EA199901055A1 (es)
HU (1) HUP9900521A3 (es)
IL (1) IL122897A0 (es)
MA (1) MA23953A1 (es)
MX (1) MX9800809A (es)
NO (1) NO980384L (es)
NZ (1) NZ315632A (es)
OA (1) OA10659A (es)
PL (1) PL325242A1 (es)
SK (1) SK11098A3 (es)
TR (1) TR199800156T1 (es)
UY (1) UY24297A1 (es)
WO (1) WO1997004750A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
KR20010034588A (ko) * 1998-03-11 2001-04-25 피터 기딩스 조성물
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
CZ306435B6 (cs) 2000-12-14 2017-01-25 Ortho-Mcneil Pharmaceutical, Inc. Steroidní hormonální přípravek a způsob jeho přípravy
US20070202179A1 (en) * 2004-04-09 2007-08-30 FAULKNER Patrick Low Dose Pharmaceutical Products
WO2026018155A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with long-acting non-cns penetrant muscarinic antagonists
WO2026018154A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with non-cns penetrant muscarinic antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
DE69034146T2 (de) * 1989-04-13 2005-07-14 Beecham Group P.L.C., Brentford Chemische Verbindungen
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
NZ315632A (en) 1999-11-29
NO980384D0 (no) 1998-01-28
AR004178A1 (es) 1998-11-04
MX9800809A (es) 1998-04-30
EA199901055A1 (ru) 2000-06-26
CZ24798A3 (cs) 1998-06-17
EP0841902A2 (en) 1998-05-20
DZ2077A1 (fr) 2002-07-22
BR9609804A (pt) 1999-07-06
AP9801170A0 (en) 1998-01-31
JPH11510493A (ja) 1999-09-14
PL325242A1 (en) 1998-07-06
UY24297A1 (es) 1997-01-23
SK11098A3 (en) 1998-07-08
EA199800179A1 (ru) 1998-10-29
CN1196677A (zh) 1998-10-21
KR19990035972A (ko) 1999-05-25
TR199800156T1 (xx) 1998-04-21
CA2228048A1 (en) 1997-02-13
AU6738496A (en) 1997-02-26
NO980384L (no) 1998-03-26
EA000740B1 (ru) 2000-02-28
WO1997004750A3 (en) 1997-03-27
HUP9900521A2 (hu) 1999-06-28
HUP9900521A3 (en) 2001-04-28
WO1997004750A2 (en) 1997-02-13
OA10659A (en) 2002-09-18
AU716961B2 (en) 2000-03-09
AP858A (en) 2000-07-12
BG102266A (en) 1998-10-30
IL122897A0 (en) 1998-08-16

Similar Documents

Publication Publication Date Title
MA26410A1 (fr) Formulations pharmaceutiques et procede pour leur production.
EP0723469A4 (en) CURVED ELECTRODES AND METHOD FOR DAMAGE GENERATION
FR2685916B1 (fr) Inhibiteurs mixtes de la no synthase et de la cyclooxygenase, ainsi qu'un procede pour leur preparation.
MA26508A1 (fr) Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
MA23528A1 (fr) Procede de preparation de produits pharmaceutiques
MA22521A1 (fr) Compositions anti- transpirantes en batonnets-gels contenant un derive de la 2-oxazolidinone, et procede pour leur preparation
FR10C0011I2 (fr) Derive de benzamidoxime, procede de production, et bactericide agrohorticole
MA23395A1 (fr) Procede de preparation de nouvelles formulations
MA23942A1 (fr) Formulation nouvelle contenant de la paroxetine, et procede pour sa preparation
FR2780728B1 (fr) Sel de paroxetine nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant
FR2772617B1 (fr) Comprime de progesterone et son procede de preparation
FR2739860B1 (fr) Complexes amphiphiles, procede pour leur preparation et compositions en renfermant
MA25418A1 (fr) Procede pour produire des preparations pharmaceutiques solides rapidement decomposables.
FR2722210B1 (fr) Nouvelles streptogramines et procede de preparation de streptogramines par mutasynthese
FR2729653B1 (fr) Procede de dephosphatation ameliore des eaux residuaires
EP0763097A4 (en) METHOD FOR PRODUCING TETRAHYDROISOALPHASIC ACID
MA23953A1 (fr) Procede nouveau pour formuler des formes posologiques solides, et formes posologiques ainsi produites
MA26708A1 (fr) Derive d'indole nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant
MA24183A1 (fr) Procede pour la preparation de compositions pharmaceutiques a base de diclofenac
MA22866A1 (fr) Procede pour la preparation des composes pour le traitement des troubles neuro-degeneratifs .
FR2700956B1 (fr) Composition cosmetique et pharmaceutique et procede pour sa preparation.
MA24346A1 (fr) Procede pour la preparation de composes anti-inflammatoires et analgesiques
FR2727314B1 (fr) Procede pour la deformation permanente des matieres keratiniques
MA24586A1 (fr) Formes posologiques de sertraline et procede par leur preparation.
EP0823904A4 (en) Process for the preparation of spiroindolines